Going digital in its 2nd year, the Blood-Brain Barrier (BBB) Summit is the industry’s definitive BBB conference focused on sharing the latest scientific advances, data and key lessons learned for transporting more […]

Taking place on 3 – 4 September 2020 in Berlin, ProcureCon Pharma is your only opportunity to benchmark with the leaders of pharma procurement. Join 120+ senior procurement professionals from […]

After an exceptionally successful inaugural launch last year, the 2nd Annual Glioblastoma Drug Development Summit returns this year in an exclusive virtual format. GBM Drug Development is the only devoted meeting for large pharma, […]

SMi is proud to announce the inaugural Prefilled Syringes San Francisco event taking place in September 2020. The global pre-filled syringes market was valued at $4.9 billion in 2018 and […]

Future Pharma September 14 – 15, 2020 Boston Marriott Long Wharf, Boston, MA www.pharmaforce.wbresearch.com Future Pharma is a two-day event that brings together heads of brands and franchises, marketing, sales […]

Via the latest data driven case studies from academic and industry pioneers, the 2nd RAS Targeted Drug Development Summit (running digitally this year!) will shine a spotlight on optimizing the selectivity […]

The #1 event for oligonucleotide, peptide, CRISPR and mRNA therapeutic leaders. Join us for top-notch networking, high-level industry expert speakers, innovative company presentations, interactive scientific poster presentations, and diverse attendee […]

Transforming to a digital platform for the eleventh year, the World Bispecific Summit will continue to deliver a greater scope and penetration of innovative technical content than any other meeting. […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

With deals in the protein degradation market reaching nearly $2 billion and unique degradation ideas coming into play such as LYTACs and ENDTACs, eyes are focused on how much further […]

The inaugural Gene Therapy for Inherited Metabolic Disorders Summit will put the spotlight on the understanding of topics from the physiopathology of disease through to the nuances of dosing and […]

Accelerating the Development of Gamma Delta T Therapies in Oncology Join us on Wednesday, September 30, to discuss the precise mechanisms of γδT cells, examine donor selection for allogeneic therapies, […]

The Digital 5th PREDiCT: 3D Oncology & Tissue Models Summit will return this September, with defined tracks and a fresh speaker line-up, bringing together preclinical scientists to discuss adoption and commercialization of […]

Built with insights from the likes of AbbVie, Sanofi, Amgen and Takeda; CDD for Biologics Summit has been specifically designed to help biopharma companies define strategies to further adapt computational […]

HOSTED BY: HEUFT LED BY: DAN MCKEE General Manager, HEUFT USA Inc Dan McKee is the General Manager of HEUFT USA. He has spent 25 years working with high-speed quality […]

As a vital tool for providing quantifiable data on cell characteristics, flow cytometry is an integral part of diagnostics and the assessment of therapeutic efficacy. Talks will also explore the […]

qPCR & Digital PCR are the most essential techniques used for quantification of nucleic acid molecules in molecular biology and diagnostics. Where qPCR is considered as a powerful technique that […]

This conference offers experts working in the biopharmaceutical industry as well as academia the opportunity to examine the latest developments in the field with dedicated congress presentations, panel discussions and […]

Animal Health Investment USA is a premier investment forum showcasing the most exciting partner opportunities in animal health and connecting those businesses together with financial investors and strategic corporate partners. […]

Off the back of the newly released first-in-human data utilizing PROTACs, it is more than ever evident that the field of targeted protein degradation is redefining the therapeutic landscape across […]

The Congress will explore novel strategies and developments in plant genomics and gene editing through a series of case studies and an examination of the latest scientific research. Leaders from […]

Case studies across the two days will examine developments in biopesticides and biostimulants and the application of new research in increasing crop yield, improving soil health & nutrient uptake, and […]

The meeting will examine the symbiotic relationships between microbes and plants through case studies in plant and soil microbiomes. Academic and industry leaders will discuss new research into the rhizosphere, […]

The 5th Microbiome Movement – Drug Development Summit (October 19-21, Digital Event - EDT) continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community […]

After the challenges of 2020 with the Covid-19 pandemic, this is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for […]

SMi are proud to announce the 7th annual conference: Pre-Filled Syringes East Coast 2020 26-27 October 2020 Boston, USA Sheraton Boston Hotel http://www.pfsamericas.com/pjwl Innovations in parenteral device and product development SMi […]

Smithers’ 9th annual Extractables and Leachables USA conference is returning. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain and making […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

Realise the Commercial Potential of Gene Therapies The 4th Annual Gene Therapy for Rare Disorders Europe is dedicated to overcoming manufacturing, clinical, and commercialisation challenges drug developers face when delivering gene therapies to market. With new European […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]